View in EDS HTML Full Text PDF Full Text

LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area.

Saved in:
Bibliographic Details
Title: LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area.
Authors: Zhao L; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China., Liu J; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China., Liu Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China., Huang Z; Center for Observational Research, Amgen China, Shanghai, China., Ye X; Center for Observational Research, Amgen China, Shanghai, China., Lange JL; Center for Observational Research, Amgen Inc., Thousand Oaks, USA., Dhalwani N; Center for Observational Research, Amgen Inc., Thousand Oaks, USA., Yang F; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China., Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China., Chen K; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China., Zhang H; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China., Zhou J; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China. 1020202613@cpu.edu.cn.
Source: Advances in therapy [Adv Ther] 2025 Jun; Vol. 42 (6), pp. 2874-2887. Date of Electronic Publication: 2025 Apr 25.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40279014
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Huang+Z%22">Huang Z</searchLink>; Center for Observational Research, Amgen China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ye+X%22">Ye X</searchLink>; Center for Observational Research, Amgen China, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lange+JL%22">Lange JL</searchLink>; Center for Observational Research, Amgen Inc., Thousand Oaks, USA.<br /><searchLink fieldCode="AU" term="%22Dhalwani+N%22">Dhalwani N</searchLink>; Center for Observational Research, Amgen Inc., Thousand Oaks, USA.<br /><searchLink fieldCode="AU" term="%22Yang+F%22">Yang F</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.<br /><searchLink fieldCode="AU" term="%22Zhou+J%22">Zhou J</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China. 1020202613@cpu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Jun; Vol. 42 (6), pp. 2874-2887. <i>Date of Electronic Publication: </i>2025 Apr 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40279014
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-025-03199-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2874
    Titles:
      – TitleFull: LDL-C Reduction with Evolocumab Among Patients with ASCVD in China: Real-World Evidence from Tianjin Metropolitan Area.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao L
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Huang Z
      – PersonEntity:
          Name:
            NameFull: Ye X
      – PersonEntity:
          Name:
            NameFull: Lange JL
      – PersonEntity:
          Name:
            NameFull: Dhalwani N
      – PersonEntity:
          Name:
            NameFull: Yang F
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Zhou J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1